Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Christina Soteriou grew up eating a Mediterranean diet in Cyprus. It's considered one of the healthiest ways to eat, and emphasizes plant-based protein sources like beans. All are not peaking at ...

Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

By Dr. Arshpreet Saraan Weight loss injectables have been making headlines in the papers and across social media the past couple of years, but how much do we really know about them?   Ozempic, Wegovy, ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...